Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-12

Clinical Trial Update: The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients [Phase 3]

View source ↗

Summary

Phase 3 trial exploring magnesium supplementation effects on exercise tolerance, quality of life, and outcomes in chronic heart failure patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium (magnesium)

Snippet

Sponsor: Sheba Medical Center | Conditions: Magnesium Deficiency, Heart Failure | Phase 3 | Status: UNKNOWN